Donald Robert Schemel - May 25, 2021 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role: Director, 10%+ Owner
Signature: /s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol: PBLA
Transactions as of: May 25, 2021
Transactions value $: $0
Form type: 4
Date filed: 5/27/2021, 08:52 PM
Next filing: Oct 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBLA	Common Stock	Award	$0	+4.32K	+4.68%	$0.00	96.6K	May 25, 2021	Direct
holding	PBLA	Common Stock						283K	May 25, 2021	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBLA	Stock Option (right to buy)	Award	$0	+12.4K		$0.00	12.4K	May 25, 2021	Common Stock	12.4K	$4.17	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Scheduled to vest and become exercisable in four equal increments on August 25, 2021, November 24, 2021, February 25, 2022 and the earlier of May 31, 2022 and the day before the company's annual meeting of stockholders to be held in 2022.